Learn about Herceptin® (trastuzumab), a targeted therapy approved for HER2+ metastatic breast cancer treatment. See full safety & Boxed Warnings for more information.

Mar 3, 2025 · Trastuzumab deruxtecan is FDA-approved for the treatment of HER2-positive metastatic breast cancers that have progressed on at least one past HER2-targeted therapy for metastatic …

Aug 10, 2021 · Targeted Drug Therapy for Breast Cancer Targeted drug therapy uses medicines that are directed at (target) proteins on breast cancer cells that help them grow, spread, and live longer. …

Oct 22, 2025 · Herceptin (chemical name: trastuzumab) is a HER2 inhibitor targeted therapy. Herceptin works against HER2-positive breast cancers by blocking the ability of the cancer cells to receive …

Abstract For decades, HER2-positive breast cancer was associated with poor outcomes and higher mortality rates than other breast cancer subtypes. However, the advent of Trastuzumab (Herceptin) …

Apr 17, 2025 · Learn how targeted therapies, including monoclonal antibodies (such as Herceptin or Trastuzumab), can be used to treat breast cancer.

Apr 14, 2024 · Find out all you need to know about Herceptin (trastuzumab) for early and more advanced HER2-positive breast cancer, including what to expect, outcomes, side effects, and more.

Trastuzumab (Herceptin) is a targeted therapy for treating breast cancer. Find out when it's used, how it works and possible side effects.

Targeted therapies—a form of precision medicine—have represented some of the most important breakthroughs in breast cancer research. Today, oncologists have numerous targeted therapies to …

Nov 7, 2024 · Herceptin, a HER2 inhibitor targeted therapy, treats breast cancer. Learn if it's right for you and more here.